David D. Allison - 16 Jun 2023 Form 4 Insider Report for IMPEL PHARMACEUTICALS INC

Role
Director
Signature
/s/ John Hoekman, Ph.D. as attorney-in-fact
Issuer symbol
N/A
Transactions as of
16 Jun 2023
Net transactions value
$0
Form type
4
Filing time
20 Jun 2023, 18:36:10 UTC
Previous filing
24 Feb 2023
Next filing
09 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Stock Option (right to buy) Award $0 +13,222 $0.000000 13,222 16 Jun 2023 Common Stock 13,222 $1.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is 100% vested on June 16, 2024.